POET Technologies and Semtech Launch 1.6T Optical Receivers for AI Networks
POET's Optical Interposer platform integrates Semtech FiberEdge® technology to achieve cutting-edge sensitivity…
DataGrail Summit: California Privacy Protection Agency Head Tom Kemp to Deliver Keynote on Protecting State’s Privacy Enforcement, Legislation & Federal Safeguards
SAN FRANCISCO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- As AI accelerates and…
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 29, 2025 19:15 ET | Source: Artelo Biosciences SOLANA BEACH, Calif.,…
InboxAlly to Showcase Inbox-First Deliverability at LeadsCon Connect 2025 in Chicago
September 29, 2025 10:00 ET | Source: InboxAlly New York, NY, Sept.…
TrustStrategy Launches AI-Driven Quant Investment Platform to Advance Global Trading Technologies
Image by TrustStrategy MIAMI, Sept. 29, 2025 (GLOBE NEWSWIRE) -- TrustStrategy, an…
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth
September 26, 2025 16:05 ET | Source: Silynxcom Ltd. Netanya, Israel, Sept.…
Maris-Tech Announces Financial Results for the Six Months Ended June 30, 2025
September 26, 2025 16:04 ET | Source: Maris-Tech Ltd. The company continues…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…